Literature DB >> 33572391

Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening.

Ilaria Cicalini1,2, Damiana Pieragostino1,3, Cristiano Rizzo4, Sara Verrocchio1,2, Daniela Semeraro1,2, Mirco Zucchelli1,3, Silvia Di Michele5, Carlo Dionisi-Vici4, Liborio Stuppia1,6, Vincenzo De Laurenzi1,3, Ines Bucci1,2, Claudia Rossi1,6.   

Abstract

Biotinidase (BTD) deficiency is an autosomal recessive inherited neurocutaneous disorder. BTD recycles the vitamin biotin, a coenzyme essential for the function of four biotin-dependent carboxylases, including propionyl-CoA carboxylase, 3-methylcrotonyl-CoA carboxylase, pyruvate carboxylase, and acetyl-CoA carboxylase. Due to deficient activities of the carboxylases, BTD deficiency is also recognized as late-onset multiple carboxylase deficiency and is associated with secondary alterations in the metabolism of amino acids, carbohydrates, and fatty acids. BTD deficiency can be classified as "profound", with less than 10% of mean normal activity, and as "partial" with 10-30% of mean normal activity. Newborn screening (NBS) of BTD deficiency is performed in most countries and is able to detect both variants. Moreover, mild metabolic alterations related to carboxylase deficiency in profound BTD deficiency could result and possibly be revealed in the metabolic profile by tandem mass spectrometry (MS/MS) NBS. Here, we report the case of a newborn female infant with an initial suspected BTD deficiency at the NBS test, finally confirmed as a partial variant by molecular testing. Although BTD deficiency was partial, interestingly her metabolic profile at birth and during the follow-up tests revealed, for the first time, alterations in specific acylcarnitines as a possible result of the deficient activity of biotin-dependent carboxylases.

Entities:  

Keywords:  biotinidase deficiency; inborn errors of metabolism; mass spectrometry; metabolic profiling; newborn screening

Year:  2021        PMID: 33572391      PMCID: PMC7916230          DOI: 10.3390/ijerph18041659

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  22 in total

Review 1.  Expanded newborn screening by mass spectrometry: New tests, future perspectives.

Authors:  Daniela Ombrone; Elisa Giocaliere; Giulia Forni; Sabrina Malvagia; Giancarlo la Marca
Journal:  Mass Spectrom Rev       Date:  2015-05-07       Impact factor: 10.946

2.  A False-Positive Case of Methylmalonic Aciduria by Tandem Mass Spectrometry Newborn Screening Dependent on Maternal Malnutrition in Pregnancy.

Authors:  Claudia Rossi; Ilaria Cicalini; Cristiano Rizzo; Mirco Zucchelli; Ada Consalvo; Silvia Valentinuzzi; Daniela Semeraro; Giorgia Gasparroni; Patrizia Brindisino; Diego Gazzolo; Carlo Dionisi-Vici; Vincenzo De Laurenzi; Damiana Pieragostino
Journal:  Int J Environ Res Public Health       Date:  2020-05-20       Impact factor: 3.390

3.  Biotinidase knockout mice show cellular energy deficit and altered carbon metabolism gene expression similar to that of nutritional biotin deprivation: clues for the pathogenesis in the human inherited disorder.

Authors:  A Hernández-Vázquez; B Wolf; K Pindolia; D Ortega-Cuellar; R Hernández-González; A Heredia-Antúnez; I Ibarra-González; A Velázquez-Arellano
Journal:  Mol Genet Metab       Date:  2013-09-08       Impact factor: 4.797

4.  Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening.

Authors:  Georgianne L Arnold; Denise Salazar; Julie A Neidich; Pim Suwannarat; Brett H Graham; Uta Lichter-Konecki; Annet M Bosch; Kristina Cusmano-Ozog; Greg Enns; Erica L Wright; Brendan C Lanpher; Natalie N Owen; Mark H Lipson; Roberto Cerone; Paul Levy; Lee-Jun C Wong; Antal Dezsofi
Journal:  Mol Genet Metab       Date:  2012-04-20       Impact factor: 4.797

5.  Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  Erin T Strovel; Tina M Cowan; Anna I Scott; Barry Wolf
Journal:  Genet Med       Date:  2017-07-05       Impact factor: 8.822

6.  Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders.

Authors:  Péter Monostori; Glynis Klinke; Sylvia Richter; Ákos Baráth; Ralph Fingerhut; Matthias R Baumgartner; Stefan Kölker; Georg F Hoffmann; Gwendolyn Gramer; Jürgen G Okun
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

7.  New tools and approaches to newborn screening: ready to open Pandora's box?

Authors:  Can Ficicioglu
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-05

Review 8.  Biotinidase Deficiency: Prevalence, Impact And Management Strategies.

Authors:  Ebru Canda; Sema Kalkan Uçar; Mahmut Çoker
Journal:  Pediatric Health Med Ther       Date:  2020-05-04

9.  High frequency of biotinidase deficiency in Italian population identified by newborn screening.

Authors:  Silvia Funghini; Rodolfo Tonin; Sabrina Malvagia; Anna Caciotti; Maria Alice Donati; Amelia Morrone; Giancarlo la Marca
Journal:  Mol Genet Metab Rep       Date:  2020-12-05

Review 10.  Biotinidase deficiency: "if you have to have an inherited metabolic disease, this is the one to have".

Authors:  Barry Wolf
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

View more
  1 in total

1.  High Incidence of Partial Biotinidase Deficiency in the First 3 Years of a Regional Newborn Screening Program in Italy.

Authors:  Daniela Semeraro; Sara Verrocchio; Giulia Di Dalmazi; Claudia Rossi; Damiana Pieragostino; Ilaria Cicalini; Rossella Ferrante; Silvia Di Michele; Liborio Stuppia; Cristiano Rizzo; Francesca Romana Lepri; Antonio Novelli; Carlo Dionisi-Vici; Vincenzo De Laurenzi; Ines Bucci
Journal:  Int J Environ Res Public Health       Date:  2022-07-02       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.